Comments
Commented by Nico Popp on January 17th, 2022 | 12:14 CET
LVMH, Diamcor, Daimler: Luxury is more than champagne, Tesla or S-Class
What constitutes luxury is in the eye of the beholder. For some people, even a terraced house in a major German city is luxury, others focus on leisure, and for others still, it has to be jewelry or diamonds. Even though there are different ideas of luxury, there are companies that perfectly reflect the desire for something special - and are thus suitable as an investment. We present three stocks.
Read
Commented by Stefan Feulner on January 17th, 2022 | 11:20 CET
BYD, Nevada Copper, Nordex - Copper, the next run
After a prolonged sideways movement and a bottoming out in the USD 9,000 area, copper celebrated the recapture of the psychologically important USD 10,000 mark last week. The triumphant march of the red metal is likely to continue in the coming years due to the energy transition. Stronger demand is offset by scarce supply, which is being further fueled by the electrification of transport, among other things.
Read
Commented by Carsten Mainitz on January 17th, 2022 | 10:05 CET
Aspermont, SAP, Steinhoff - Unbridled growth
With focused growth and high investments in the cloud division, European software giant SAP wants to attack the US tech groups Oracle and Salesforce. The Walldorf-based Company has recognized the signs of the times; technological progress concerning a rapidly growing engineered and digital world is picking up speed. The Australian Company Aspermont, a formerly long-established publishing house, has already gone through the digital transformation. The next step is now to become a fintech group. The path has already been paved.
Read
Commented by Stefan Feulner on January 14th, 2022 | 13:29 CET
BYD, Yorkton Ventures, BMW - An expensive boom
The electric carmakers' annual figures are out, and they show rapid growth for both BYD and BMW. Despite the pandemic and the shortage of semiconductors, the automakers were able to double deliveries in some cases. The industry also expects a continued boom in e-mobility in 2022. The Association of International Motor Vehicle Manufacturers forecasts around 850,000 new registrations for electric vehicles in Germany in 2022. In addition to the sales figures, however, the prices for the raw materials required are also growing. Lithium alone, which is essential for batteries, has more than tripled in price since June of last year and is currently reaching new highs almost daily.
Read
Commented by Carsten Mainitz on January 14th, 2022 | 12:31 CET
Barrick Gold, Alerio Gold, First Majestic - Experts agree: 2022 will be the year of mining stocks
2021 was a consistently strange year. Corona surprised with more new variants, Olaf Scholz became German Chancellor and the prices for gold and silver, despite ever-rising inflation, developed downwards towards the end year. While in the past many investors have relied on cryptocurrencies as a hedge against inflation, perhaps the recent price capers of the leading cryptocurrency, Bitcoin, could make investors rethink.
Read
Commented by Mario Hose on January 14th, 2022 | 12:17 CET
Natural active ingredient against Covid-19: BioNTech, Cardiol, Novavax, Valneva in focus
At the end of the week, trading on the German stock exchanges has been rather slow so far. The German leading index DAX is quoted at a level of 15,922 points and thus around 0.01% up. The index of the second tier, MDAX, traded last at 34,626 points (-0.11%), TecDAX at 3,537 points (-0.67%) and SDAX at 15,904 points with 0.43% in the red. A study from the U.S. will influence the future development of vaccine manufacturers in connection with Covid-19, according to initial research.
Read
Commented by Stefan Feulner on January 14th, 2022 | 11:44 CET
BioNTech, Defence Therapeutics, PAION - Seizing the momentum
The Corona pandemic brought biotechnology to the forefront of society's consciousness, especially since the first vaccines were created in German laboratories. However, the biotech spectrum is much broader than pandemic vaccine research. In addition to research in medicine, the sector is playing an increasingly important role in environmental protection, agriculture and the ongoing climate change.
Read
Commented by Armin Schulz on January 14th, 2022 | 11:06 CET
Lufthansa, wallstreet:online, Block - Shares with catch-up potential
The nervousness was palpable as the US indices fell for five days in a row. Reasons for consolidation are quickly found - the Omicron variant, inflation and the fear of rising interest rates provide uncertainty for the bulls. Especially the big tech companies would suffer from an interest rate hike, and many tech stocks were already punished and investors preferred to invest in value stocks. If the interest rate hike comes, there will likely be further markdowns in the tech sector. Today, we look at three companies that we believe could be on the verge of a turnaround.
Read
Commented by Nico Popp on January 14th, 2022 | 10:13 CET
TeamViewer, Meta Materials, Deutsche Bank: Do your research and beat the market
Sometimes the technology that everyone has known for years becomes a game changer overnight. That is what happened at the beginning of the pandemic with the TeamViewer software. Sometimes things turn out differently, and innovations are so revolutionary that it takes a while for the market to recognize the potential. We examine three stocks for their innovation potential and explain whether or not the market understands the equity stories.
Read
Commented by Mario Hose on January 13th, 2022 | 18:11 CET
New research results for Covid-19: BioNTech, Cardiol, Valneva
In the afternoon of today's trading day, the German indices extended the price losses in part after a brief recovery phase. The DAX is currently trading at 15,963 points, down around 0.41%. The psychological mark of 16,000 points was exceeded at midday in phases by more than 75 points. The MDAX last traded at 34,708 points (-0.62%), TecDAX at 3,577 points (-2.26%) and SDAX at 15,976 points with 0.66% in the red. New research results for the treatment and prevention of Covid-19 provide an exciting perspective for investors.
Read